banner
HCV protease inhibitor BMS-790052, Purity ≥98%
Inquiry

Cat. No.: X24-06-ZQ890

HCV protease inhibitor BMS-790052, Purity ≥98%

Synonym: 1214735-16-6; HCV protease inhibitor; Daclatasvir

  • MDL: MFCD17129086
  • CAS Number: 1214735-16-6
  • Compound CID: 25154714
img
Product Size
5 mg; 10 mg; 50 mg; 100 mg
Price
Datasheet
MSDS
Properties
Description
BMS-790052, soluble in DMSO and ethanol and insoluble in water, targets and inhibits the function of the hepatitis C virus protease enzyme.
Molecular Weight
738.9
Molecular Formula
C40H50N8O6
Form
Lyophilized powder
Purity
≥98%
Solubility
DMSO: 129 mg/mL (174.59 mM); Water: Insoluble; Ethanol: 129 mg/mL (174.59 mM)
Identity
Confirmed by NMR/HPLC/MS.
Applications
BMS-790052 is utilized in hepatitis C research to inhibit the NS3/4A protease, which is crucial for viral replication.
Publications
Publications (0)

Publications

×
Publications

Thank you for choosing our products for your research. By sharing your publications or experimental feedback, you provide invaluable insights that help fellow scientists accelerate their discoveries. Your contribution also drives our commitment to continuous product optimization.

As a token of our appreciation, verified submissions will receive an exclusive discount code for your next order.

*Submitted research data and images may be featured on our product pages. We strictly protect your personal privacy; no sensitive contact information will ever be disclosed.

  • You can upload up to 5 images or ZIP files, and the size of a single file may not exceed 5MB.
Related Products
Quick Links

About Us

CD BioGlyco is a world-class biotechnology company with offices in many countries. Our products and services provide a viable option to what is otherwise available.

Contact Us

Copyright © CD BioGlyco. All rights reserved.
0